KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Cash (2016 - 2025)

Historic Change in Cash for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $29.8 million.

  • Fulgent Genetics' Change in Cash rose 52920.39% to $29.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year increase of 33012.09%. This contributed to the annual value of -$42.2 million for FY2024, which is 33484.17% down from last year.
  • Fulgent Genetics' Change in Cash amounted to $29.8 million in Q3 2025, which was up 52920.39% from $20.6 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Change in Cash peaked at $188.2 million during Q1 2022, and registered a low of -$214.3 million during Q2 2022.
  • For the 5-year period, Fulgent Genetics' Change in Cash averaged around $1.6 million, with its median value being $10.4 million (2024).
  • Over the last 5 years, Fulgent Genetics' Change in Cash had its largest YoY gain of 250461.89% in 2021, and its largest YoY loss of 64225.0% in 2021.
  • Over the past 5 years, Fulgent Genetics' Change in Cash (Quarter) stood at -$50.0 million in 2021, then plummeted by 78.59% to -$89.3 million in 2022, then skyrocketed by 115.01% to $13.4 million in 2023, then tumbled by 121.63% to -$2.9 million in 2024, then soared by 1126.95% to $29.8 million in 2025.
  • Its last three reported values are $29.8 million in Q3 2025, $20.6 million for Q2 2025, and $12.1 million during Q1 2025.